| Net income | 28.29M |
| Amortization of premium and discounts (Agency MBS) | |
| Amortization of restricted stock | |
| Write-down of Lehman receivable | |
| Recovery on Non-Agency MBS | |
| (Increase) decrease in interest receivable | -2.22M |
| (Increase) in prepaid expenses and other | -86.33M |
| Increase in accrued interest payable | 261K |
| (Decrease) increase in accrued expenses and payable for securities purchased | -581K |
| Net cash (used in) provided by operating activities | |
| Purchases | -185.81M |
| Principal payments | |
| Principal payments | |
| Purchase of reverse repurchase agreements | |
| Net cash (used in) provided by investing activities | |
| Borrowings from repurchase agreements | |
| Repayments on repurchase agreements | |
| Proceeds from common stock issued, net | |
| Proceeds from Series B Preferred Stock issued, net | 834K |
| Series A Preferred stock dividends paid | -207K |
| Series B Preferred stock dividends paid | |
| Common stock dividends paid | -14.4M |
| Treasury stock | 1.65M |
| Net cash provided by (used in) financing activities | |
| Net increase (decrease) in cash and cash equivalents | -3.95M |
| Cash and cash equivalents at beginning of period | 21.05M |
| Cash and cash equivalents at end of period | 17.1M |
| Cash paid for interest | 15.15M |